Philanthropic disease foundations rival VCs in life sciences investments

Nonprofit investors maintain that despite their similarities to venture capital firms, there are key differences. But the model also has drawbacks, including misaligned incentives.

Previous Patti Payne: Tina Turner musical offers actress role of a lifetime
Next VidCon prepares for first convention in Baltimore, East Coast debut